Investor Type
LinkedIn View on LinkedIn
Kenneth Harrison is a Partner at Novo Ventures.
Announced Date | Organization Name | Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|---|
obfuscated obfuscation | Hillstar Bio | Novo Holdings | Series A - Hillstar Bio | obfuscated obfuscation | |
obfuscated obfuscation | SiteOne Therapeutics | Novo Holdings | Series C - SiteOne Therapeutics | obfuscated obfuscation | |
obfuscated obfuscation | Nuvig Therapeutics | Novo Holdings | Series B - Nuvig Therapeutics | obfuscated obfuscation | |
obfuscated obfuscation | Nuvig Therapeutics | Novo Holdings | Series A - Nuvig Therapeutics | obfuscated obfuscation | |
obfuscated obfuscation | Hummingbird Bioscience | Novo Holdings | Series C - Hummingbird Bioscience | obfuscated obfuscation | |
obfuscated obfuscation | Reneo Pharmaceuticals | ![]() Novo Ventures | Series B - Reneo Pharmaceuticals | obfuscated obfuscation | |
obfuscated obfuscation | Edgewise Therapeutics | Novo Holdings | Series C - Edgewise Therapeutics | obfuscated obfuscation | |
obfuscated obfuscation | Edgewise Therapeutics | Novo Holdings | Series B - Edgewise Therapeutics | obfuscated obfuscation |